Authors: Bittner, M Meitzer, P Chen, Y Jiang, Y Seftor, E Hendrix, M Radmacher, M Simon, R Yakhini, Z Ben-Dor, A Sampas, N Dougherty, E Wang, E Marincola, F Gooden, C Lueders, J Glatfelter, A Pollock, P Carpten, J Gillanders, E Leja, D Dietrich, K Beaudry, C Berens, M Alberts, D Sondak, V Hayward, N Trent, J

Citation: M. Bittner et al., Molecular classification of cutaneous malignant melanoma by gene expression profiling, NATURE, 406(6795), 2000, pp. 536-540

Authors: Somasundaram, R Robbins, P Moonka, D Loh, E Marincola, F Patel, A Guerry, D Herlyn, D

Citation: R. Somasundaram et al., CD4(+), HLA class I-restricted, cytolytic T-lymphocyte clone against primary malignant melanoma cells, INT J CANC, 85(2), 2000, pp. 253-259

Authors: Riker, A Cormier, J Panelli, M Kammula, U Wang, E Abati, A Fetsch, P Lee, KH Steinberg, S Rosenberg, S Marincola, F

Citation: A. Riker et al., Immune selection after antigen-specific immunotherapy of melanoma, SURGERY, 126(2), 1999, pp. 112-120

Authors: Rosenberg, SA Zhai, YF Yang, JC Schwartzentruber, DJ Hwu, P Marincola, F Topalian, SL Restifo, NP Seipp, CA Einhorn, JH Roberts, B White, DE

Citation: Sa. Rosenberg et al., Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens, J NAT CANC, 90(24), 1998, pp. 1894-1900